Efficacy and Safety of Ravagalimab in Patients With Moderate-to-Severe Ulcerative Colitis: Data From a Phase 2a Trial
Year: 2026
Type: article
Abstract: The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
Source: Figshare
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7143445331
